Assessment of temperatures in the vaccine cold chain in two provinces in Lao People’s Democratic Republic: a cross-sectional pilot study

Objective

All childhood vaccines, except the oral polio vaccine, should be kept at 2–8 °C, since the vaccine potency can be damaged by heat or freezing temperature. A temperature monitoring study conducted in 2008–2009 reported challenges in cold chain management from the provincial level downwards. The present cross-sectional pilot study aimed to assess the current status of the cold chain in two provinces (Saravan and Xayabouly) of Lao People’s Democratic Republic between March–April 2016. Two types of temperature data loggers recorded the temperatures and the proportions of time exposed to < 0 or > 8 °C were calculated.

Results

The temperature remained within the appropriate range in the central and provincial storages. However, the vaccines were frequently exposed to > 8 °C in Saravan and < 0 °C in Xayabouly in the district storage. Vaccines were exposed to > 8 °C during the transportation in Saravan and to both > 8 and < 0 °C in Xayabouly. Thus, challenges in managing the cold chain in the district storage and during transportation remain, despite improvements at the provincial storage. A detailed up-to-date nationwide analysis of the current situation of the cold chain is warranted to identify the most appropriate intervention to tackle the remaining challenges.

Immunization is one of the most important achievements in public health, and a major contributor for this success is the expanded program on immunization (EPI) [1,2,3,4,5,6,7,8,9,10,11,12,13,14]. The EPI was initiated in Lao People’s Democratic Republic (Lao PDR) in 1979, and the immunization coverage has been improving since then; however, the country has experienced outbreaks of vaccine-preventable diseases lately, and one of the reasons was speculated as several steps of the cold chain potentially being compromised [15,16,17,18].

The World Health Organization and vaccine labels state that all childhood vaccines, except for oral polio vaccines, should be kept at 2–8 °C to ensure their quality, efficacy, and safety, since most vaccines are sensitive to heat or freezing temperatures [10,11,12,13, 19]. In Lao PDR, the supply chain consists of three levels. The vaccines are dispatched from the National Immunization Program (NIP) storage in the capital to the regional or provincial storage. Subsequently, they are sent to the district storage. Finally, they reach the health centers. Immunization services are provided either at the health facilities or during outreach sessions in the villages. A temperature monitoring study conducted in 2008–2009 by the United Nations Children’s Fund (UNICEF) reported several challenges in cold chain management from the provincial level downward and the vaccines were exposed both overheating and freezing [20]. A new strategy has been implemented such as continuous monitoring at storage since then. With this in mind, the present study and aimed to assess the current status of the cold chain, at all levels, in two representative provinces of Lao PDR.

This was a cross-sectional pilot study conducted from March to April 2016. Two provinces, one each in the northern and southern part of Lao PDR, were deliberately selected by the NIP since these two provinces are good representatives of all 18 provinces considering their population and geographical characteristics (Fig. 1). One district per province and five health centers per district were selected by the EPI officers of the NIP and the Provincial Health Department from each province. Sampling method is a purposive sampling and sample size was justified since this study tested feasibility and acceptability of the study protocol for a larger study in the future. The ambient temperature was not recorded in this study to avoid the complexity of the procedure for the health care workers. DTP-HepB-Hib vaccines was agreed to transport through a normal vaccine transportation route among the researchers before the study was conducted.

Map of Lao PDR showing the target two provinces https://gadm.org/maps/LAO_1.html

Full size image

Two types of temperature data loggers were used and randomly assigned to the final destination: MicroLite™ (Sato Shouji Inc., Japan) and CUSTOM™ (CUSTOM, Japan). MicroLite™ was pre-set to record temperatures every two minutes and CUSTOM™ was set to record every 5 min. The health care workers were all pre-informed about the study, however they were not informed about the monitoring intervals and the loggers were pre-set to avoid manipulations by the health care workers to minimize the bias. The recordings were started on 17/3/2016 and lasted until 11/4/2016. All data loggers and vaccines started to travel down to the provinces on 24/3/2016. A monitoring form was developed and attached with the vaccines and temperature data loggers to record the dates of events such as the arrival and departure of the vaccines. The provincial/district EPI officers and the health center staff recorded the information in the forms. The temperature data loggers and monitoring forms were packed with the vaccines in the vaccine carriers and transported using the normal transportation route. Once they reached the provincial/district storage, they were stored in the refrigerator with the vaccines until they were ready to be dispatched to the lower level.

All data were downloaded from each temperature data logger as an Excel spreadsheet or PDF file. The analysis conducted in the study was descriptive and the proportions of time exposed to < 0 and > 8 °C were calculated. The precise times (hours or minutes) of arrival and departure were not recorded, and the duration of transportation was defined from 0:00 on the departure date to 23:59 on the arrival date. The duration of storage was defined as 24 h per date not indicated as being in transportation.

Ethical considerations

No ethical clearance or informed consent was necessary, since there was no intervention or interaction with humans [10]. However, authorization to conduct this study was granted by the Ministry of Health and the Provincial Health Departments [10].

Eight and six days of recordings were analyzed for the loggers that went to Saravan (23/3/2016–31/3/2016) and Xayabouly (23/3/2016–29/3/2016), respectively.

Ambient temperature and range of temperature during the study period

Ambient temperature was not recorded in this study. The temperature ranged from 19 to 38 °C in Vientiane, capital of Lao PDR, during the study period. The temperature in Pakse and Champasak, which are located 54 km from Saravan, ranged from 21 to 37 °C, while the recorded temperatures in Saravan ranged between 0.2 and 18.0 °C; these were below the ambient temperature recorded in Pakse. The temperature in Luang Prabang, which is located 49 km from Xayabouly, ranged from 18 to 35 °C. In Xayabouly, the temperature ranged between − 3.3 and 20.4 °C [21].

Proportions of exposure to suboptimal temperature throughout the observation period

On average, the vaccines were exposed to > 8 °C for 41% of the total recorded time in Saravan (37–45%). They were not exposed to < 0 °C. The corresponding proportions in Xayabouly were 5% (5–6%) and 15% (11–19%), respectively.

Proportions of exposure to suboptimal temperature during storage

No exposure to suboptimal temperature in the central storage was observed 1 day prior to the vaccines and data loggers being dispatched (Table 1). The times spent at the provincial and district storages were 2 days in Saravan and 1 day in Xayabouly. No exposure to suboptimal temperature was seen in the provincial storage in both provinces. In Saravan, the loggers recorded more than 80% of the time spent in the storage as being at above 8 °C (range of proportion: 84–100%, range of temperature: 7.9–11.9 °C), whereas there was no exposure to < 0 °C at the district storage. In Xayabouly, no exposure to > 8 °C was recorded; however, more than 50% of the time, the temperature was recorded as < 0 °C (range of proportion: 44–68%, range of temperature: − 2.7 to 6.3 °C) at the district storage.

Proportions of exposure to suboptimal temperature during transportation

The times required to transport the vaccines from the capital to the province, from the province to the district, and from the district to the health centers were 2, 1 and 1 day, respectively, in both provinces (Table 2). The vaccines were exposed to > 8 °C at an average of 48% (45–50%), 51% (41–61%), and 32% (27–39%) of the time spent for transportation from the capital to province, from province to district, and from district to health center, respectively in Saravan. They were never exposed to < 0 °C. The differences in maximum and minimum temperature were 11.0, 11.4 and 17.8 °C respectively (capital → province: maximum 15.5 °C, minimum 4.5 °C; province → district: max 16.8 °C, min 5.4 °C; district → health center: max 18.0 °C, min 0.2 °C). The vaccines were exposed to > 8 °C at an average of 6% (5–10%), 18% (13–25%), and 8% (2–11%) of the time during transportation in Xayabouly and to < 0 °C at an average of 0%, 12% (9–17%), and 32% (8–51%) of the time during transportation from the capital to province, from province to district, and from district to health center, respectively. The ranges of temperature were 16.8, 15.8 and 23.7 °C, respectively (capital → province: max 18.4 °C, min 1.6 °C; province → district: max 14.3 °C, min –2.7 °C; district → health center: max 20.4 °C, min − 3.3 °C).

This pilot study aimed to identify the current temperature control of vaccines in Lao PDR. This study discovered challenges during the storage at the district and during transportation, and these challenges differed according to the region. The vaccines were exposed to both overheating and freezing.

The study of temperature monitoring in 2008–2009 by UNICEF pointed out significant weaknesses of cold chains in terms of material and human resources from the provincial level downwards, including improperly maintained or outdated refrigeration equipment, poor compliance with cold-chain procedures, inadequate monitoring, and poor understanding of the dangers of freezing vaccines [20]. The present study showed that the temperature remained within the appropriate range in the provincial level storage. However, at the district storage, the vaccines were still exposed to either overheating or freezing during a high proportion of the time spent there. The temperature exceeded 5 °C above or below the appropriate temperature range. Besides the weaknesses pointed out by UNICEF, the studies from five different countries described an unstable power supply or lack of contingency plans during power cuts a lack of training on the cold chain, insufficient supervision to implement proper monitoring, lack of access to guidelines or Standard Operating Procedures, and improper management of the budget for the cold chain might be root causes of inappropriate cold chain management below the district level [10, 11, 13, 14, 19, 20, 22].

In the present study, the vaccines were exposed to either overheating or freezing throughout the transportation from the central to the health centres as well, however the differences in the maximum and minimum temperature was greater than 10 °C, suggesting that the temperature control during transport was more unstable than that in storage. In addition to the reasons mentioned above, the studies from four different countries described the characteristic reasons during transport as unstable temperature control during transportation might be due to improper management of ice packs, unexpected delays in transportation due to road or vehicle conditions, and improper means of transporting vaccine [10, 11, 13, 19, 22]. The study by Nanthavong et al. mentioned the possibility of cold chain breaks during transport in Lao PDR [17].

Emphasis has long been placed on avoiding high temperatures, but, as this study also showed, recent studies have reported exposure to freezing temperature at many stages during distribution [12, 23, 24]. The World Health Organization guidelines specify that the hepatitis B, diphtheria–tetanus–pertussis, diphtheria–tetanus, and tetanus toxoid vaccine must not be frozen [12]. To avoid freezing of vaccines, Kolwaite et al. conducted a pilot study to assess the effect of “out-of-the-cold-chain” storage in Lao PDR and discovered improved Hepatitis B dose coverage without an increase in adverse reactions [25]. Some innovative solutions should be considered in the context of developing countries, such as a computerizing temperature monitoring system, development of thermostable vaccines, development of a compact prefilled vaccination device, or the use of a cold box that can manage temperature control on its own for a long duration [10, 14, 24, 26].

This study identified the current status of cold chain management for vaccines in two provinces in Lao PDR. Despite improvements in the cold chain management at the provincial storage, it remains a challenge to manage the cold chain in the district storage and during transportation. Both overheating and freezing of vaccines were identified, and these findings differed according to the region. A detailed up-to-date analysis of the current situation of the cold chain at all levels is warranted in Lao PDR, such as a nationwide cold chain assessment to implement proper context-specific interventions for different cold chain management issues.

This study has several limitations. First, this study only covered two out of 18 provinces. Second, the ambient temperature was not recorded; however, we speculate that the temperature loggers were travelled or stored in the vaccine carriers or refrigerator as instructed, since the available temperatures from the neighboring provinces were higher than those recorded in the loggers. Third, the temperature management in the health center storages and during the outreach activities were not monitored. Fourth, the precise times of arrival and departure were not recorded and the transportation period may thus also include time spent in the storage. Finally, all health care workers were conscious that the temperature was being monitored, thus, their vaccine handling may have been changed. The results should be carefully interpreted by considering these limitations.

EPI:

expanded program on immunization

Lao PDR:

Lao People’s Democratic Republic

NIP:

National Immunization Program

UNICEF:

United Nations Children’s Fund

TK, VB, KP, CP, and AX carried out data collection in the field. TK, MN, HO, YM, MM, and MH conducted the data analysis and produced the first draft of the manuscript. TK edited the final version of the manuscript and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We acknowledge all the health care workers who took parts in this study and we respect their hard work in the field despite of the challenging situation. We also would like to thank Dr. Hiromi Obara and experts from development partners including JICA, UNICEF, and WHO for offering insightful comments.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Ethics approval and consent to participate

No ethical clearance or informed consent was necessary, since there was no intervention or interaction with humans. However, authorization to conduct this study was granted by the Ministry of Health and the Provincial Health Departments.

Funding

This work was supported by The Grant of National Center for Global Health and Medicine (27-4, 28-1) and Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development (AMED). The funding source had no control over the study.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Affiliations

1. Bureau of International Cooperation, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 1628655, Japan

   • Tomomi Kitamura
   • , Masataro Norizuki
   • , Hironori Okabayashi
   •  & Masahiko Hachiya

2. National Immunization Program, Ministry of Health, Lao PDR, Simuang Road, Vientiane, Lao People’s Democratic Republic

   • Viraneth Bouakhasith
   • , Kongxay Phounphenghack
   • , Chansay Pathammavong
   •  & Anonh Xeuatvongsa

3. Laboratory of Rubella, Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Musashimurayama, Tokyo, 208-0011, Japan

   • Yoshio Mori

4. Department of Global Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa, 9208640, Japan

   • Munehito Machida

Corresponding author

Correspondence to Tomomi Kitamura.

Reprints and Permissions